Study Summary
This trial is testing a new way to do radiation therapy for prostate cancer that has come back after surgery. They will use a special scan to find where the cancer is and give a high dose of radiation to that area while sparing the healthy tissue.
- Prostate Cancer
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 2 Secondary · Reporting Duration: Baseline to 5-year follow-up
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Molecular Imaging Informed Radiation Dose Escalation and De-escalation
1 of 1
Experimental Treatment
60 Total Participants · 1 Treatment Group
Primary Treatment: Image-guided Radiotherapy · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · Male Participants · 6 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is there currently availability for participants in this trial?
"The details hosted on clinicaltrials.gov suggest that this trial is still open for patient recruitment, having been first published November 1st 2022 and amended most recently on October 6th 2022." - Anonymous Online Contributor
How many volunteers will be included in this research initiative?
"Affirmative. According to the clinicaltrials.gov, this scientific exploration is still recruiting members of the public - having been posted on November 1st 2022 and revised recently in October 6th 2022. 60 participants are necessary for its success from a single site." - Anonymous Online Contributor